We would like to thank Dr. Song for the interest and valuable comments regarding our
manuscript [1]. Our study demonstrated that a noninvasive urine test—based on a simple …

In 2020, nearly 600 000 individuals worldwide were diagnosed with bladder cancer, making
it the tenth most common cancer globally [1], with approximately 25% of cases diagnosed as …

Background Patients with muscle-invasive bladder cancer (MIBC) who receive radiotherapy
with curative intent are followed by imaging, cystoscopy, and urine cytology. However …

(UroToday. com) The 2024 European Association of Urology (EAU) annual congress held in
Paris, France between April 5 th and 8 th was host to a plenary session addressing imaging …

Crafting precision medicine requires specific knowledge of the patient's disease and what
makes it unique. As physicians determine these specifics, they can match patients to the …

We undertook a pilot study to evaluate whether measuring common BC-associated
mutations in urinary DNA can contribute to the monitoring of treatment responses in patients …

Cancer cells release cell-free DNA with tumor-specific molecular alterations into circulation,
known as circulating tumor DNA (ctDNA). Numerous studies have underscored the …

Liquid biopsy analyses encompass a wide range of materials and analytes derived from
tumors. Although blood tests are commonly used for liquid biopsy analysis, other fluids like …

Results We observed no degradation of ucfDNA stored with 10 mM EDTA at room
temperature over a 7-day time period, compared to significant degradation of ucfDNA stored …

Background Recently, non-invasive urine-based MRD assays have demonstrated the ability
to detect deep molecular alterations in bladder cancer patients, which may greatly improve …